Keyword: Teva Pharmaceuticals
News
02.02.2024
-
Israeli generics manufacturer Teva Pharmaceuticals intends to divest its active pharmaceutical ingredient (API) business, Teva API (TAPI). A standalone business unit of...
News
10.07.2023
-
Teva Pharmaceuticals considers selling its $2 billion active pharmaceutical ingredients (API) unit as part of its "Pivot to Growth" strategy.
News
12.06.2013
- Pfizer said Teva Pharmaceuticals Industries and Sun Pharmaceutical Industries would pay $2.15 billion to settle a patent suit related to its acid-reflux drug. This is the first...
News
10.05.2013
- A federal judge in New York on Friday declined to temporarily halt a court order directing the U.S. Food and Drug Administration to make emergency contraception available over the...
News
30.11.2012
- Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, forecast profit and revenue for calendar 2013 that fell short of analysts' estimates. The Israel-based...
News
01.11.2012
- Teva Pharmaceutical Industries, the world's biggest generic drugmaker, posted adjusted quarterly profit that beat expectations as strong U.S. revenue offset lower European generic...
News
02.10.2012
- U.S. antitrust regulators found no wrongdoing in a deal made four years ago between German drugmaker Bayer and a division of Teva Pharmaceuticals to end patent litigation over the...
News
24.05.2012
- Teva Pharmaceutical Industries, the world's largest maker of generic drugs, has cut its profit and revenue forecasts for 2012, blaming weaker economies and healthcare spending cuts...
